Načítá se...
Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
PURPOSE: Intravenous (IV) zoledronic acid (ZA) is commonly used to delay skeletal complications secondary to bone metastases. However, the time associated with ZA administration may represent a significant burden to healthcare providers and patients. This study assessed the time associated with IV Z...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304336/ https://ncbi.nlm.nih.gov/pubmed/22427731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S27693 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|